These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7757285)

  • 1. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel.
    Gagliardi G; Kandemir O; Liu D; Guida M; Benvestito S; Ruers TG; Benjamin IS; Northover JM; Stamp GW; Talbot IC
    Virchows Arch; 1995; 426(2):149-54. PubMed ID: 7757285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival.
    Syrigos KN; Krausz T; Waxman J; Pandha H; Rowlinson-Busza G; Verne J; Epenetos AA; Pignatelli M
    Int J Cancer; 1995 Dec; 64(6):367-70. PubMed ID: 8550236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence.
    Day RM; Hao X; Ilyas M; Daszak P; Talbot IC; Forbes A
    Virchows Arch; 1999 Feb; 434(2):121-5. PubMed ID: 10071246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours.
    Van Aken J; Cuvelier CA; De Wever N; Roels J; Gao Y; Mareel MM
    Pathol Res Pract; 1993 Nov; 189(9):975-8. PubMed ID: 8302730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of beta-catenin, E-cadherin, and P-cadherin expressions in neoplastic progression of colorectal mucosa: an immunohistochemical study.
    Savas B; Ensari A; Percinel S; Kuzu I; Kuzu MA; Bektas M; Cetinkaya H; Kursun N
    Acta Gastroenterol Belg; 2007; 70(4):339-44. PubMed ID: 18330089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.
    Pignatelli M; Ansari TW; Gunter P; Liu D; Hirano S; Takeichi M; Klöppel G; Lemoine NR
    J Pathol; 1994 Dec; 174(4):243-8. PubMed ID: 7884585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
    Hao X; Palazzo JP; Ilyas M; Tomlinson I; Talbot IC
    Anticancer Res; 1997; 17(3C):2241-7. PubMed ID: 9216695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1993 Nov; 68(5):926-31. PubMed ID: 7692919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.
    Bendardaf R; Sharif-Askari FS; Sharif-Askari NS; Syrjänen K; Pyrhönen S
    Anticancer Res; 2019 Apr; 39(4):1953-1957. PubMed ID: 30952738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Snail-1, E-cadherin and claudin-1 expression in colorectal adenomas and carcinomas.
    Bezdekova M; Brychtova S; Sedlakova E; Langova K; Brychta T; Belej K
    Int J Mol Sci; 2012; 13(2):1632-1643. PubMed ID: 22408413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
    Jang TJ
    Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas.
    van der Wurff AA; Vermeulen SJ; van der Linden EP; Mareel MM; Bosman FT; Arends JW
    J Pathol; 1997 Jul; 182(3):325-30. PubMed ID: 9349236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-CAM expression in normal, premalignant, and malignant colon mucosa.
    van der Wurff AA; ten Kate J; van der Linden EP; Dinjens WN; Arends JW; Bosman FT
    J Pathol; 1992 Nov; 168(3):287-91. PubMed ID: 1469507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis.
    Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M
    Proc Nutr Soc; 2003 Feb; 62(1):229-36. PubMed ID: 12756972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin gene alterations are rare events in thyroid tumors.
    Soares P; Berx G; van Roy F; Sobrinho-Simões M
    Int J Cancer; 1997 Jan; 70(1):32-8. PubMed ID: 8985087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin in human colorectal cancer.
    Khoursheed MA; Mathew TC; Makar RR; Louis S; Asfar SK; Al-Sayer HM; Dashti HM; Al-Bader A
    Surgeon; 2003 Apr; 1(2):86-91. PubMed ID: 15573626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma.
    Shimoyama Y; Hirohashi S
    Cancer Lett; 1991 May; 57(2):131-5. PubMed ID: 1851053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin downregulation at the infiltrating tumour front is associated with histological grade and stage in colorectal carcinoma of Malaysians.
    Dass SD; Cheah PL; Ong DB; Teoh KH; Looi LM
    Malays J Pathol; 2015 Apr; 37(1):19-24. PubMed ID: 25890609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.